This Advisory is based on Technical Assistance Publication (TAP) 21, Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice. It discusses the development of the counseling competencies and the validated research on which they are based, provides a simplified overview of their structure and the elements of a typical competency, and outlines how these competencies are changing the field of substance use disorder (SUD) treatment nationwide. The Advisory also addresses the critical role of cultural competency.
Dashboard: Filter Bricks
Main page content
Based on Treatment Improvement Protocol (TIP) 41, Substance Abuse Treatment: Group Therapy, this Advisory provides an overview of goals, processes, group-specific approaches, resources, and common elements that support favorable outcomes in group therapy.
This Advisory, based on TIP 38, Integrating Substance Abuse Treatment and Vocational Services, presents strategies and resources for SUD treatment counselors and clinic directors to improve outcomes for clients in recovery by helping them find and keep employment and deal with workplace stresses. This Advisory is directed to programs serving clients who are unemployed, underemployed, or struggling in workplace settings.
This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.
This guide explores barriers to accessing substance use disorder and mental health treatment services in rural communities, and the benefits of telehealth for these communities. It assists practitioners with implementing telehealth technologies as a means to increase access to services.
This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.
This advisory answers questions about the seriousness of prescription drug misuse. It explains how people become dependent on prescription drugs, and treatment options. The advisory also offers necessary treatment resources for professionals.
This advisory defines protracted withdrawal and identifies specific withdrawal symptoms associated with alcohol, opioids, methamphetamine, cocaine, marijuana, and benzodiazepines. The advisory also explains how protracted withdrawal differs from acute withdrawal, and gives tips to help clients manage it in recovery.